AI-Driven Biotech Stocks Surge Amid Mergers and Acquisitions Frenzy
The biotechnology sector is currently undergoing an impressive revival, marked by a substantial surge in investor interest and activity. After a challenging period characterized by market instability and decreased investor confidence, biotech stocks are once again drawing attention, fueled by groundbreaking advancements in artificial intelligence (ai) and a resurgence of mergers and acquisitions (M&A) activity….